Dr Daniela Branzan (University of Leipzig, Leipzig, Germany) discusses the results from the first-in-man clinical application of the TrackCath System, which aims to support the identification and cannulation of aortic side branches with a guiding catheter or a guidewire.

Interviewer: William Cadden

Videographer: Natascha Wienand

Transcript Below : 

Well, basically the TrackCath System it's a blood flow velocity measurement system that was developed to reduce the dose of X-ray and the contrast media during complex EVA procedures. And basically, the catheter was tested in the flirts in-human trial and it was shown that it was safe. We had no complication related to the catheter. And basically it was very successful. In the study, we used to catheterize from 50 orifices, 49 which is very successful performance of this technology. So I think in the future, this catheter would help us to perform this complex aortic procedure and reducing the X-ray dose and the contrast medium, and will be part of our instrumentarium during these cases.